Gundy S, Baki M, Bodrogi I, Czeizel A
Department of Human Genetics and Teratology, WHO Collaborating Centre for the Community Control of Hereditary Diseases, Budapest, Hungary.
Oncology. 1992;49(5):376-80. doi: 10.1159/000227076.
Chromosome aberrations were studied in peripheral blood lymphocytes from untreated testicular cancer patients and others treated with chemo- and/or radiotherapy. A distinct increase in spontaneous aberrations over the level of healthy controls was found in patients treated with surgery alone. Our data suggest the existence of a certain degree of chromosome instability which may be a factor in the development of malignancy for testicular tumours, too. The frequency of aberrant cells was much higher in treated groups than in controls, and the total of aberrations was therapy related. The frequency of aberrant cells was the highest in the first 2 years after the end of treatments similarly to the results of 3 serially examined individuals. The decrease in aberrant cells was time-dependently gradual only in X-ray-treated patients. Real conclusions about the nature of therapy-related persistence of aberrant cells can be drawn from the study of a sufficient number of testicular cancer patients studied more than 1 year after the end of treatments.
对未经治疗的睾丸癌患者以及接受化疗和/或放疗的其他患者的外周血淋巴细胞中的染色体畸变进行了研究。仅接受手术治疗的患者,其自发畸变水平明显高于健康对照组。我们的数据表明存在一定程度的染色体不稳定性,这也可能是睾丸肿瘤发生恶性病变的一个因素。治疗组中异常细胞的频率远高于对照组,且畸变总数与治疗相关。与连续检查的3名个体的结果相似,治疗结束后的头两年内,异常细胞的频率最高。仅在接受X射线治疗的患者中,异常细胞的减少呈时间依赖性逐渐下降。关于治疗相关的异常细胞持续存在的性质的实际结论,可以从对足够数量的睾丸癌患者在治疗结束后1年以上进行的研究中得出。